US64049M2098 - NEO - 120159 (XNCM)
NEOGENOMICS INC Hinterlegungsschein
16,48 USD
Aktuelle Kurse von NEOGENOMICS INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
NEO
|
USD
|
19.09.2024 23:29
|
16,48 USD
| 16,16 USD | 1,98 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | 2,55 % | 0,12 % | 26,67 % | 11,96 % | 29,05 % | -24,37 % |
Firmenprofil zu NEOGENOMICS INC Hinterlegungsschein
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
Unternehmensdaten NEOGENOMICS INC Hinterlegungsschein
Name NEOGENOMICS INC
Firma NeoGenomics, Inc.
Symbol NEO
Website https://www.neogenomics.com
Heimatbörse
NASDAQ CAPITAL MARKET
WKN 120159
ISIN US64049M2098
Wertpapierart Hinterlegungsschein
Sektor Healthcare
Branche Medical - Diagnostics & Research
CEO Mr. Christopher Michael Smith BSc
Marktkapitalisierung 2 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 2,1 T
Adresse 9490 NeoGenomics Way, 33912 Fort Myers
IPO Datum 2004-03-16
Dividenden von NEOGENOMICS INC
Ex-Datum | Dividende pro Aktie |
---|---|
17.12.2020 | 0,40 USD |
Aktien Kennungs-Wechsel
Datum | Von | Zu |
---|---|---|
17.12.2012 | NGNM | NEO |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | NG9.F |
NASDAQ | NEO |
Weitere Aktien
Investoren die NEOGENOMICS INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024